首页> 外文期刊>European archives of psychiatry and clinical neuroscience >Therapeutic targets in major psychiatric disorders revisited
【24h】

Therapeutic targets in major psychiatric disorders revisited

机译:再次探讨主要精神疾病的治疗目标

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Following the hypothesis of schizophrenia being a disorder of impaired neural plasticity, numerous clinical trials have investigated the efficacy of non-invasive brain stimulation techniques in modulating plasticity and the treatment of this disorder. Hasan et al. [1] in this interesting invited review outline the four main stimulation protocols rTMS, UDP, PAS and tDCS which in some aspects have shown promising evidence to be an effective add-on treatment in schizophrenia. Alterations in GABAergic and glutamater-gic neurotransmission may be improved by brain stimulation. However, since the optimal stimulation technique, target region and disease state for an intervention are still insufficient, the authors plead for funding further basic research in this area. Based on effects on sigma-1 receptors, which are involved in neuronal plasticity, synapto-genesis and myelination, add-on fluvoxamine treatment has been shown to improve negative symptoms in schizophrenia.
机译:继精神分裂症是神经可塑性受损的疾病的假说之后,许多临床试验研究了非侵入性脑刺激技术在调节可塑性和治疗该疾病中的功效。哈桑等。 [1]在这个有趣的受邀评论中,概述了四种主要的刺激方案rTMS,UDP,PAS和tDCS,它们在某些方面已显示出有希望的证据是有效的精神分裂症附加疗法。脑刺激可以改善GABA能和谷氨酸能神经传递的改变。但是,由于最佳的刺激技术,用于干预的目标区域和疾病状态仍然不足,因此作者呼吁为该领域的基础研究提供资金。基于对涉及神经元可塑性,突触发生和髓鞘形成的sigma-1受体的影响,已显示氟伏沙明治疗可改善精神分裂症的不良症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号